You just read:

Mirum Pharmaceuticals Presents New Data Demonstrating Durable Improvements in Clinical Outcome Measures in Patients with PFIC2 and Alagille Syndrome Treated with Maralixibat

News provided by

Mirum Pharmaceuticals

Apr 15, 2019, 08:00 ET